Efficacy and safety of the combination of bevacizumab (BEV) and temsirolimus (TEM) in patients with metastatic renal cancer (mRCC) after first-line anti-VEGF treatment: A Hellenic... von Koutsoukos, K., Zagouri, F., Tzannis, K., Karavasilis, V., Samantas, E., Aravantinos, G., Koutras, A., Gkerzelis, I., Chamylos, E., Kostouros, E., Lykka, M., Tsironis, G., Dimitriadis, I., Liontos, M., Fountzilas, G., Dimopoulos, M., Bamias, A.

Volltext

Renal artery infarction in the SARS-Cov-2 era: A systematic review of case reports von Kozyrakis, Diomidis, Kallinikas, Georgios, Zarkadas, Anastasios, Bozios, Dimitris, Konstantinopoulos, Vasileios, Charonis, Georgios, Safioleas, Konstantinos, Filios, Athanasios, Rodinos, Evangelos, Mytiliniou, Despoina, Vlassopoulos, Gerasimos, Gkerzelis, Ioannis, Filios, Panagiotis

Volltext

The combination of bevacizumab/temsirolimus after first-line anti-VEGF therapy in advanced renal-cell carcinoma: a clinical and biomarker study von Bamias, Aristotelis, Karavasilis, Vasilios, Gavalas, Nikolaos, Tzannis, Kimon, Samantas, Epaminontas, Aravantinos, Gerasimos, Koutras, Angelos, Gkerzelis, Ioannis, Kostouros, Euthymios, Koutsoukos, Konstantinos, Zagouri, Flora, Fountzilas, George, Dimopoulos, Meletios-Athanasios

Volltext